Trials / Conditions / Early Onset Alzheimer Disease

Early Onset Alzheimer Disease

11 registered clinical trials studyying Early Onset Alzheimer Disease — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Study of Donanemab, RG6289, or the Combination of Donanemab and RG6289 in Presenilin 1 (PSEN1) E280A Mutatio NCT06996730	Banner Health	Phase 2 / Phase 3
Recruiting	FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases NCT06539169	xCures	—
Recruiting	A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD NCT05231785	Alnylam Pharmaceuticals	Phase 1
Active Not Recruiting	48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease NCT04002583	Mayo Clinic	N/A
Completed	Gene Therapy for APOE4 Homozygote of Alzheimer's Disease NCT03634007	Lexeo Therapeutics	Phase 1 / Phase 2
Completed	Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease NCT07294586	Amoneta Diagnostics SAS	—
Recruiting	Longitudinal Early-onset Alzheimer's Disease Study Protocol NCT03507257	Indiana University	—
Completed	RHAPSODY-plus: Online Counseling for Family Caregivers of Patients With Young Onset Dementia NCT03923517	Technical University of Munich	N/A
Unknown	Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain NCT02875496	ElMindA Ltd	—
Terminated	Sleep Apnea in Early to Mid-Stage Alzheimer's Disease NCT01400542	Centre Hospitalier Universitaire de Saint Etienne	—
Completed	Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease (MNEMOSYNE) NCT00867828	NeuroBioPharm Inc.	Phase 4